Life stage dependent effects of neonicotinoid exposure on honey bee hypopharyngeal gland development

Selina Bruckner1, Lars Straub2, Laura Villamar-Bouza3

  • 1Institute of Bee Health, Vetsuisse Faculty, University of Bern, Bern, Switzerland; Department of Entomology & Plant Pathology, Auburn University, Auburn, AL, USA; Department of Entomology, The Pennsylvania State University, University Park, PA, USA.

Functional Apis mellifera honey bee colonies rely on collaborative brood care typically performed by nurse bees with well-developed hypopharyngeal glands (HPGs). Neonicotinoids, widely used insecticides, have been shown to negatively affect HPG development when worker bees were exposed to field-realistic concentrations either as brood or adults. To date, it is unknown whether timing of neonicotinoid exposure influences the severity of these observed negative effects on HPGs. To address this, we conducted a fully-crossed field experiment assessing potential effects of a neonicotinoid blend (clothianidin and thiamethoxam combined) on worker HPGs when exposed during different life stages. We found that neonicotinoid exposure during the brood stage, but not the adult stage, significantly influenced subsequent HPG development. Since HPG morphogenesis begins during the brood stage, neonicotinoid-induced stress possibly impaired this process, resulting in smaller glands once these individuals became adult nurses. Because HPG productivity is correlated to their size, smaller glands as a result of neonicotinoid exposure could negatively affect colony functionality.

Related Concept Videos

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...